[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Pentoxifylline with a dose of 400 mg, made by Farabi Pharmaceutical Company, Iran, was prescribed to patients weighing less than 70 kg every 12 hours and to patients weighing more than 70 kg every 8 hours. This group receives only Pentoxifylline for two days from the hospitalization day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Vitamin D3 (oral capsule) with a dose of 50,000 units, one capsule at hospitalization day, hydroxychloroquine tablets with a dose of 200 mg every 12 hours for two days from the hospitalization day, serum therapy (2.5 to 3.5 liters) and Nasal Prong two to eight liters (depending on the patient's dyspnea condition) were prescribed.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 971, "treatment_name": "Pentoxifylline", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]